Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction

NCT02397317 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT02397317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02397317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction
Lead sponsor
University of Sydney
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
June 19, 2020
Enrollment
49 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer